Latest
Fecal Shedding of SARS-CoV-2 Outlasts That of Respiratory Tract
Survival Benefit Seen With Atezolizumab-Bevacizumab Combo in Unresectable HCC
Effects of the COVID-19 Pandemic on North American Gastroenterology and Endoscopy Practices
Associations Between Gastrointestinal Infection and New-Onset IBD
Filgotinib Associated With Clinical Remission in Ulcerative Colitis Study
Incomplete Resection of Colorectal Polyps: Data from a Systematic Review and Meta-Analysis
Evidence Supporting Dietary Supplement Use for COVID-19 Lacking
New Guidance for Commencing IBD Treatment During the COVID-19 Pandemic
Besifovir Dipivoxil Maleate Effective, Safe for Long-Term Treatment of Chronic Hepatitis B
Qinlock Approved As Fourth-Line Treatment of Advanced GI Stromal Tumors
Women Have Lower Overall Risk for NAFLD, But Higher Risk for Advanced Fibrosis
Risk for Colorectal Cancer Relatively Low in Patients with Ulcerative Colitis
Hemophagocytic Lymphohistiocytosis and Inflammatory Bowel Disease
Endoscopic Surveillance Safe and Effective, with Low Risk of Colorectal Cancer in Long-term Study
Long-Term Outcomes in Patients with Acute Severe Ulcerative Colitis Responding to IVS
High H. pylori Eradication Rate with Rifabutin-Based Therapy
Infliximab Clearance Associated with Colectomy Requirement in Patients with Acute Severe Ulcerative Colitis
Liver Forum Releases Recommendations on Diet, Exercise in NAFLD/NASH
Bi-Dimensional Shear Wave Elastography Produces Comparable Liver Stiffness Measurements to Conventional Method
Featured Content
-
COVID-19: Atypical GI Presentations
There are increasing data to support that many patients with COVID-19 can develop a myriad of gastrointestinal symptoms, which include mild diarrhea, nausea, vomiting and abdominal pain. -
The United States Test Against COVID-19
Mitigating the spread of a virus as infectious as SARS-CoV-2 requires having ample and accurate diagnostic tests available. However, in the United States, community transmission began to occur before adequate testing measures could be implemented. -
The Most Cases of COVID-19 Are in the United States: 5 Updates on the Pandemic
The effects of the COVID-19 pandemic have caused more significant change than previously expected as the United States now has the most cases worldwide. -
Ulcerative Colitis and Fecal Transplantation: Where are We Now?
It is thought that dysregulation of the gut microbiome could cause increased production of pro-inflammatory toxins that can predispose patients to the development of UC. -
The Relationship Between Gut Microbiota and Neurodegenerative Disorders
The microbiota-gut-brain axis represents a bidirectional communication pathway through which the gut microbiota may influence the CNS.
American Gastroenterological Association Releases Obesity Practice Guide
Gastroenterologists are in a unique position to lead a multidisciplinary care team for patients with obesity.
Can Vitamin D Supplementation Improve Progression-Free Survival in Gastrointestinal Cancers?
In 2 randomized clinical trials, investigators sought to determine if use of vitamin D supplements improved PFS and RFS for patients with digestive tract cancers.
USPSTF Reaffirms Recommendation for HBV Screening During Pregnancy
The United States Preventative Service Task Force has issued a statement that reaffirms its 2009 recommendations for screening pregnant women for hepatitis B virus.
Gastroesophageal Reflux Symptoms May Persist After Gastric Bypass in Severe Obesity
Patients with severe obesity and gastroesophageal reflux disease may not experience long-term symptom relief from gastric bypass.
Timing Pneumococcal Vaccinations and Immunosuppressive Therapy in IBD
Patients with irritable bowel disease planning to start immunosuppressive therapy may need to receive a pneumococcal vaccination beforehand.
